|

control group Clinical Trials

4 actively recruiting trials

No change since May 2026

Also known as: Group 3

Pipeline

Phase 4: 1Phase 1/2: 1Phase 2/3: 1

Top Sponsors

  • The First Hospital of Jilin University1
  • Ever Supreme Bio Technology Co., Ltd.1
  • Beni-Suef University1
  • Anhui Provincial Hospital1

Indications

Other4 trials

Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria
Phase 2/3
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
Phase 1/2
The Effects of Some Antihyperglycemic Drugs on Cognitive Function and Risk of Depression of Diabetic Patients
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.